OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening
Patricia Murphy, Dinesh Kumar, Gary Zammit, et al.
Journal of Clinical Sleep Medicine (2020) Vol. 16, Iss. 5, pp. 765-773
Open Access | Times Cited: 56
Patricia Murphy, Dinesh Kumar, Gary Zammit, et al.
Journal of Clinical Sleep Medicine (2020) Vol. 16, Iss. 5, pp. 765-773
Open Access | Times Cited: 56
Showing 26-50 of 56 citing articles:
Efficacy and Safety of Lemborexant for Insomnia Patients With Nocturia—A Prospective Study
Yoshikazu Togo, Yohei Kaizuka, Seiji Nagasawa, et al.
LUTS Lower Urinary Tract Symptoms (2024) Vol. 16, Iss. 6
Closed Access | Times Cited: 1
Yoshikazu Togo, Yohei Kaizuka, Seiji Nagasawa, et al.
LUTS Lower Urinary Tract Symptoms (2024) Vol. 16, Iss. 6
Closed Access | Times Cited: 1
Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors
Takashi Ueno, Yukiko Miyajima, Ishani Landry, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 5, pp. 455-466
Open Access | Times Cited: 10
Takashi Ueno, Yukiko Miyajima, Ishani Landry, et al.
CPT Pharmacometrics & Systems Pharmacology (2021) Vol. 10, Iss. 5, pp. 455-466
Open Access | Times Cited: 10
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning
Hubert Bland, Xiaodong Li, Eric Mangin, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 4, pp. 414-420
Closed Access | Times Cited: 10
Hubert Bland, Xiaodong Li, Eric Mangin, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 4, pp. 414-420
Closed Access | Times Cited: 10
The effect of lemborexant for insomnia disorder
Hidenobu Suzuki, Hiroyuki Hibino
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 10
Hidenobu Suzuki, Hiroyuki Hibino
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 10
Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents
Shunya Ikeda, Mie Azuma, Kenichi Fujimoto, et al.
Psychological Medicine (2022) Vol. 52, Iss. 13, pp. 2822-2834
Open Access | Times Cited: 7
Shunya Ikeda, Mie Azuma, Kenichi Fujimoto, et al.
Psychological Medicine (2022) Vol. 52, Iss. 13, pp. 2822-2834
Open Access | Times Cited: 7
Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Effect of alcohol coadministration on the pharmacodynamics, pharmacokinetics, and safety of lemborexant: A randomized, placebo-controlled crossover study
Ishani Landry, Nancy Hall, Jagadeesh Aluri, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 6, pp. 745-755
Open Access | Times Cited: 6
Ishani Landry, Nancy Hall, Jagadeesh Aluri, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 6, pp. 745-755
Open Access | Times Cited: 6
Evaluating lemborexant for the treatment of insomnia
Gary Zammit, Andrew D. Krystal
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1235-1243
Closed Access | Times Cited: 8
Gary Zammit, Andrew D. Krystal
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1235-1243
Closed Access | Times Cited: 8
Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study
Sho Horikoshi, Itaru Miura, Yuhei Suzuki, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 10, pp. 1753-1758
Closed Access | Times Cited: 3
Sho Horikoshi, Itaru Miura, Yuhei Suzuki, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 10, pp. 1753-1758
Closed Access | Times Cited: 3
Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant/TS‐142 in healthy Japanese participants following single/multiple dosing: Randomized, double‐blind, placebo‐controlled phase‐1 studies
Daiji Kambe, Sayaka Hasegawa, Yumiko Imadera, et al.
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 133, Iss. 5, pp. 576-591
Open Access | Times Cited: 3
Daiji Kambe, Sayaka Hasegawa, Yumiko Imadera, et al.
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 133, Iss. 5, pp. 576-591
Open Access | Times Cited: 3
Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy
Maha Ahmad, James Kelly, C. Brendan Montano, et al.
Sleep Medicine X (2023) Vol. 7, pp. 100098-100098
Open Access | Times Cited: 3
Maha Ahmad, James Kelly, C. Brendan Montano, et al.
Sleep Medicine X (2023) Vol. 7, pp. 100098-100098
Open Access | Times Cited: 3
Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 6
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 6
The effects of different dosages of dual orexin receptor antagonists and zolpidem on sleep and cognitive function: A meta-analysis and systematic review
Mengzhen Zhou, Rujia Liu, Zhengqi Xie
Sleep Epidemiology (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 2
Mengzhen Zhou, Rujia Liu, Zhengqi Xie
Sleep Epidemiology (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 2
A comprehensive review of the use of lemborexant in treating insomnia
Pesala Pavan Kumar Reddy, Jayasheela S Hiremath, Sanatkumar Bharamu Nyamagoud, et al.
MGM Journal of Medical Sciences (2024) Vol. 11, Iss. 1, pp. 146-151
Open Access
Pesala Pavan Kumar Reddy, Jayasheela S Hiremath, Sanatkumar Bharamu Nyamagoud, et al.
MGM Journal of Medical Sciences (2024) Vol. 11, Iss. 1, pp. 146-151
Open Access
Evaluation of sunobinop for next-day residual effects in healthy participants
Alessandra Cipriano, Ram P. Kapil, Mingyan Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Alessandra Cipriano, Ram P. Kapil, Mingyan Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Short-Term Efficacy and Safety of Suvorexant and Lemborexant: A Retrospective Study
Koki Mori, M Kimura, Eiseki Usami
Cureus (2024)
Open Access
Koki Mori, M Kimura, Eiseki Usami
Cureus (2024)
Open Access
Nighttime safety of daridorexant: Evaluation of responsiveness to an external noise stimulus, postural stability, walking, and cognitive function
Massimo Magliocca, Ingrid Koopmans, Cédric Vaillant, et al.
Journal of Psychopharmacology (2024)
Closed Access
Massimo Magliocca, Ingrid Koopmans, Cédric Vaillant, et al.
Journal of Psychopharmacology (2024)
Closed Access
Effects of new hypnotic drugs on cognition: A systematic review and network meta-analysis
Mengzhen Zhou, Rujia Liu, Jiyou Tang, et al.
Sleep Medicine X (2023) Vol. 6, pp. 100094-100094
Open Access | Times Cited: 1
Mengzhen Zhou, Rujia Liu, Jiyou Tang, et al.
Sleep Medicine X (2023) Vol. 6, pp. 100094-100094
Open Access | Times Cited: 1
C-L Case Conference: Insomnia Disorder
Vanessa Aversa, Raed Hawa, Elliott Kyung Lee, et al.
Journal of the Academy of Consultation-Liaison Psychiatry (2023) Vol. 65, Iss. 3, pp. 293-301
Closed Access | Times Cited: 1
Vanessa Aversa, Raed Hawa, Elliott Kyung Lee, et al.
Journal of the Academy of Consultation-Liaison Psychiatry (2023) Vol. 65, Iss. 3, pp. 293-301
Closed Access | Times Cited: 1
Overview of Medication Treatment for Co-Morbid Insomnia and Sleep Apnea (COMISA)
Alan Lowe, Megan S. Lowe
Springer eBooks (2022), pp. 195-201
Closed Access | Times Cited: 2
Alan Lowe, Megan S. Lowe
Springer eBooks (2022), pp. 195-201
Closed Access | Times Cited: 2
Recent Advances in Psychopharmacology
Alexander J. Poznanski, Esther Akinyemi
Advances in Psychiatry and Behavioral Health (2022) Vol. 2, Iss. 1, pp. 253-266
Closed Access | Times Cited: 2
Alexander J. Poznanski, Esther Akinyemi
Advances in Psychiatry and Behavioral Health (2022) Vol. 2, Iss. 1, pp. 253-266
Closed Access | Times Cited: 2
Preclinical and clinical efficacy of orexin receptor antagonist Lemborexant (Dayvigo<sup>®</sup>) on insomnia patients
Michinori Koebisu, Noriyuki Koyama, Maika Nishida, et al.
Folia Pharmacologica Japonica (2021) Vol. 156, Iss. 2, pp. 114-119
Open Access | Times Cited: 2
Michinori Koebisu, Noriyuki Koyama, Maika Nishida, et al.
Folia Pharmacologica Japonica (2021) Vol. 156, Iss. 2, pp. 114-119
Open Access | Times Cited: 2
Balance dysfunction the most significant cause of in-hospital falls in patients taking hypnotic drugs: A retrospective study
Ryuki Hashida, Hiroo Matsuse, Shinji YOKOYAMA, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0272832-e0272832
Open Access | Times Cited: 1
Ryuki Hashida, Hiroo Matsuse, Shinji YOKOYAMA, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0272832-e0272832
Open Access | Times Cited: 1
Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Clinical Pharmacology in Drug Development (2021) Vol. 10, Iss. 9, pp. 1089-1098
Open Access | Times Cited: 1
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Clinical Pharmacology in Drug Development (2021) Vol. 10, Iss. 9, pp. 1089-1098
Open Access | Times Cited: 1
